EXI1:XETRA:XETRA-iShares SLI UCITS ETF (DE) (EUR)

ETF | Others |

Last Closing

USD 138.58

Change

-0.52 (-0.37)%

Market Cap

USD 0.37B

Volume

2.17K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-07-02 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.47 (+0.92%)

USD 548.90B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.14 (+0.83%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.21 (+0.79%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.20 (+0.71%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.20 (+0.83%)

USD 157.79B
8R80:XETRA Amundi Index Solutions - Amund..

+0.96 (+0.64%)

USD 103.20B
JARI:XETRA Amundi Index Solutions - Amund..

+0.22 (+0.49%)

USD 102.92B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.43 (+0.83%)

USD 85.64B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+0.28 (+0.05%)

USD 80.38B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

+0.19 (+0.86%)

USD 79.79B

ETFs Containing EXI1:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 5.22% 49% F 52% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.22% 48% F 51% F
Trailing 12 Months  
Capital Gain 11.38% 57% F 60% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 11.38% 56% F 58% F
Trailing 5 Years  
Capital Gain 46.37% 69% C- 70% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 46.37% 69% C- 68% D+
Average Annual (5 Year Horizon)  
Capital Gain 8.40% 69% C- 66% D+
Dividend Return 8.71% 69% C- 65% D
Total Return N/A 26% F 34% F
Risk Return Profile  
Volatility (Standard Deviation) 11.71% 53% F 62% D
Risk Adjusted Return 74.35% 86% B+ 87% B+
Market Capitalization 0.37B 61% D- 54% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.